Drug profile

The FDA adverse-event record for Rabies In Hhh Adj Pfizer Kv

452 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Rabies In Hhh Adj Pfizer Kv. See the species affected, top reactions, and outcomes below.

452
adverse-event reports
14.8%
death-coded share
Dog
most-reported species
125
Vomiting - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
452
Total Reports
67
Deaths Reported
14.8%
Death Rate

Active Ingredients

Rabies In Hhh Adj Pfizer Kv

Administration Routes

SubcutaneousUnknownIntramuscular

Species Affected

Dog 361
Cat 91

Most Affected Breeds

Crossbred Canine/dog 100
Domestic Shorthair 65
Retriever - Labrador 25
Chihuahua 16
Terrier (unspecified) 15
Shih Tzu 15
Retriever - Golden 13
Bulldog - French 12
Domestic Mediumhair 12
Terrier - Yorkshire 11

Most Reported Reactions

Vomiting 125
Lethargy (see also Central nervous system depression in 'Neurological') 90
Emesis (multiple) 74
Diarrhoea 48
Seizure NOS 39
Fever 38
Death 36
Not eating 35
Ataxia 31
Death by euthanasia 28
Anorexia 25
Decreased appetite 25

Outcome Breakdown

Recovered/Normal
186 (41.2%)
Ongoing
150 (33.2%)
Outcome Unknown
39 (8.6%)
Died
39 (8.6%)
Euthanized
28 (6.2%)
Recovered with Sequela
10 (2.2%)

Rabies In Hhh Adj Pfizer Kv Adverse Event Insights

452 reports name Rabies In Hhh Adj Pfizer Kv; 67 recorded a death outcome (14.8% of reported events, not a population-level mortality rate). Active ingredient: Rabies In Hhh Adj Pfizer Kv. Administration routes: Subcutaneous, Unknown, Intramuscular.

By species: Dog (361 reports), Cat (91 reports). By breed: Crossbred Canine/dog (100), Domestic Shorthair (65), Retriever - Labrador (25).

Leading clinical signs: Vomiting (125), Lethargy (see also Central nervous system depression in 'Neurological') (90), Emesis (multiple) (74), Diarrhoea (48). Outcome, 452 coded reports: Recovered/Normal leads at 41.2%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.